Key result
Advanced age, warfarin use, and chronic liver or kidney disease were associated with increased risk of acute GI bleeding (overall incidence 3.3%) in veteran patients prescribed clopidogrel post-MI.
Why the study?
What are the risk factors for acute gastrointestinal bleeding in veteran patients prescribed clopidogrel following myocardial infarction?
Cohort (n=3,218)
Yes
What are the risk factors for acute gastrointestinal bleeding in veteran patients prescribed clopidogrel following myocardial infarction?
Advanced age, warfarin use, and chronic liver or kidney disease are significant risk factors for acute GI bleeding in post-MI patients prescribed clopidogrel.
May inform closer monitoring in high-risk veterans on clopidogrel post-MI; leaves open need for prospective validation of risk modification.
OBJECTIVE: Our aim was to identify risk factors for acute gastrointestinal (GI) bleeding in patients with myocardial infarction (MI) who were prescribed clopidogrel following hospital discharge. METHODS: Data were collected retrospectively from patients treated in Veteran Affairs hospitals in Ohio, USA, from 2001 to 2008 with a primary diagnosis of MI (International Classification of Diseases, 9th Revision) and a prescription for clopidogrel filled within 48 h of discharge. Primary outcome was acute GI bleeding after discharge. RESULTS: Acute GI bleeding occurred in 107 of 3218 patients. Bleeding occurred in those who were elder (66.2 vs. 62.4 years, P = 0.0002), had lower glomerular filtration rate (74 vs. 81 mL/min, P = 0.024), had filled prescription for warfarin (15.9% vs. 6.9%, P = 0.0004), diagnosed as atrial fibrillation (20.6% vs. 11.1%, P = 0.003), chronic liver (5.6% vs. 2.2%, P = 0.018) or kidney disease (29.0% vs. 19.4%, P = 0.016). A risk model and GI bleed risk score were developed and showed that patients with age >65 years, use of warfarin, the presence of chronic liver or kidney disease were at increased risk for GI bleeding. CONCLUSIONS: Veterans patients of advanced age, using warfarin and with chronic liver and kidney disease may be at increased risk of GI bleeding when prescribed clopidogrel following MI. A scoring system may help to identify patients at high risk for GI bleeding.
No takes yet. Share an insight, caveat, or question.
Cuschieri et al. (2013) conducted a cohort in Myocardial infarction (n=3,218). Advanced age, warfarin use, chronic liver or kidney disease vs. Absence of these risk factors was evaluated on acute GI bleeding after discharge. Advanced age, warfarin use, and chronic liver or kidney disease were associated with increased risk of acute GI bleeding (overall incidence 3.3%) in veteran patients prescribed clopidogrel post-MI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: